Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis

NCT00185510 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: Methylprednisolone Aceponate (Advantan, BAY86-4862)
DRUG: Placebo

Sponsor

LEO Pharma

Collaborators

[object Object]